期刊文献+

金黄杆菌属连续5年耐药性监测与β-内酰胺酶的检测 被引量:11

Drug Resistance and Detection of β-Lactamase from Chryseobacterium spp:A Five Year Surveillance
暂未订购
导出
摘要 目的了解医院金黄杆菌属的分离和耐药情况,并探索其产生耐药的机制。方法对医院5年间分离的金黄杆菌属进行鉴定和K-B法药敏试验;同时选择43株脑膜脓毒金黄杆菌、16株产吲哚金黄杆菌和10株黏金黄杆菌共69株,用琼脂稀释法检测14种抗菌药物的最低抑菌浓度(MIC);用三维试验和协同试验筛选超广谱β-内酰胺酶及碳青酶烯酶。结果2001年1月-2005年12月5年间共检出金黄杆菌属1128株,其中脑膜脓毒金黄杆菌占88.3%、产吲哚金黄杆菌占8.0%、黏金黄杆菌占2.9%,其他金黄杆菌占0.8%;金黄杆菌属除了喹诺酮类抗菌药物的MIC50和MIC90较低外,其余的抗菌药物均很高;脑膜脓毒金黄杆菌金属酶阳性率为60.5%,产吲哚金黄杆菌阳性率为68.8%,黏金黄杆菌阳性率为90.0%。结论金黄杆菌属对多种抗菌药物耐药,不同种类的金黄杆菌属对不同的抗菌药物耐药性有很大的差异,金黄杆菌属的耐药机制主要是产生了以金属酶为主的β-内酰胺酶。 OBJECTIVE To investigate the isolation and drug resistance of Chryseobacterium spp in our hospital, and to explore the mechanisms of drug resistance. METHODS Bacteria were identified in our hospital for the last five years (Jan 2001- Dec 2005) and the antimicrobial susceptibility was tested by Kirby-Bauer plate dilution method. Forty-three isolates of C. meningosepticum, 16 isolates of C. indologenes and 10 isolates of C. gleum were isolated and selected for further studies. Minimum inhibitory concentrations (MICs) against 14 antibiotics were determined by the agar dilution method. Extended-spectrum β-lactamase (ESBL) and carbapenemase were detected by three-dimensional test and 2-mercaptopropionic acid inhibitory test. RESULTS One thousand and one hundred twenty-eight Chryseobacterium and others strains in total were isolated during the described period. Among them C. meningosepticum, C. indologenes, C. gleum, and other Chryseobacterium species were 88.3%, 8.0%, 2.9%, 0.6% and 0.2%, respectively. The resistant ratios against antibiotics containing enzyme inhibitors were lower than other antibiotics. The MICs0 and MIC90 against most antibiotics were high except for quinolones. As for carbapenemase, the positive rate was 60. 5%, 68.8% and 90.0% in C. meningosepticum, C. indologenes, and C. gleurn, respectively. CONCLUSIONS Chryseobacterium are highly resistant against a variety numbers of antibiotics. Nevertheless, there exists a significant difference in the resistance against different antibiotics for different species of Chryseobacterium. The major drug resistant mechanism in Chryseobacterium is due to the production of β-lactamases, especially metallo-β-lactamases.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2008年第10期1476-1479,共4页 Chinese Journal of Nosocomiology
关键词 金黄杆菌属 Β-内酰胺酶 耐药性 Chryseobacteriurn spp Beta-lactamase Drug Resistance
  • 相关文献

参考文献6

  • 1张嵘,朱百荣,周田美,董小勤,杨青,孔海深,吕火祥.杭州市脑膜炎败血黄杆菌的分离和药敏谱分析[J].中华检验医学杂志,2003,26(8):481-483. 被引量:18
  • 2董晓勤,周田美,施新颜,吴盛海,范建中,汪涛.非发酵菌感染的临床分布和耐药谱分析[J].中华医院感染学杂志,2004,14(7):809-811. 被引量:48
  • 3National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial testing[S]. Eleventh information supplement. NCCLS Doucuments,2006.40.108.
  • 4Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening rnetallo-β-1actamase-producing Gram-negative bacteria by using thiol compounds[J].J Clin Microbiol,2000, 38(1) :40-43.
  • 5Jeffrey T,Kirby HS,Sader TR,etal. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001)[J]. J Clin Microbiol, 2004,42(1) : 445-448.
  • 6Chen GX,Zhang R,Zhou HW. Heterogeneity of metallo-beta-lactamases in clinical isolates of Chryseobacterium meningosepticum from Hangzhou, China[J]. J Antimierob Chemother, 2006,57 (4) : 750-752.

二级参考文献15

  • 1[3]Vay C,Almuzara M,Mattera J,et al.Evaluation of API 20 NE (version 6.0) in rare Gram-negative non-glucose-fermenting bacilli[J] Rev Argent Microbiol,2003,35(3): 133-137.
  • 2Liu CE, Wong WW, Yang SP, et al. Flavobacterium meningosepticum bacteriemia: an analysis of 16 cases. Zhanghua YiXue Za Zhi-(Taipei) ,1999,62: 125-132.
  • 3Merino LA, Ronconi MC, Marin M, et al. Non-fermenting Gramnegative bacilli: distribution in clinical specimens and antimicrobial susceptibility. Rev Latinoam Microbiol, 1999, 41:279-284.
  • 4Tizer KB, Cervia JS, Dunn AM, et al. Succesdul combination vancomycin and rifampin therapy in a newborn with communityacquired Flavobacterium meningosepticum neonatal meningitis.Pediatr Infect Dis J, 1995,14:916-917.
  • 5Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother, 1997, 41:2738-2741.
  • 6Lira LC, Low JA, Chart KM. Chryseobacterium meningosepticum (Flavobacterium meniagosepticum) - a report of five cases in a local hospital. Ann Acad Med Singapore, 1999,28: 857-860.
  • 7Nulens E, Bussels B, Bols A, et al. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect, 2001,7:391-393.
  • 8National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4^th ed. Approved Standard M7-A4. Pennsylvania:NCCLS, 1997.76-77.
  • 9Pokrywka M, Viazanko K, Medvick J, et al. A Fiavobacterium meningosepticum outbreak among intensive care patients. Am J Infect Control, 1993,21:139-145.
  • 10Hoque SN, Graham J, Kaufmann ME, et al. Chryseobacterium( Flavobacterium ) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect, 2001,47:188-192.

共引文献62

同被引文献73

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部